Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 85, Issue 8, Pages 5416-5427Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.0c00125
Keywords
-
Categories
Funding
- National Institutes of Health [R35 GM124661]
- NIH [S10OD016360, S10RR024664]
- NSF [9977422, 1625923, 0320648]
- NIH Center Grant [P20GM103418]
Ask authors/readers for more resources
We report the conversion of aryl methyl ethers and phenols into six fluoroalkyl analogues through late-stage functionalization of a natural product-derived FDA-approved therapeutic. This series of short synthetic sequences exploits a combination of both modern and traditional methods and demonstrates that some recently reported methods do not always work as well as desired on a natural product-like scaffold. Nonetheless, reaction optimization can deliver sufficient quantities of each target analogue for medicinal chemistry purposes. In some cases, classical reactions and synthetic sequences still outcompete modern organofluorine transformations, which should encourage the continued search for improved reactions. Overall, the project provides a valuable synthetic roadmap for medicinal chemists to access a range of fluorinated therapeutic candidates with distinct physicochemical properties relative to the original O-based analogue.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available